Related Experiment Video
Updated: May 10, 2026

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
Published on: April 19, 2011
Cardiovascular adenosine receptors: expression, actions and interactions.
John P Headrick1, Kevin J Ashton, Roselyn B Rose'meyer
1Heart Foundation Research Centre, Griffith Health Institute, Griffith University, Southport, QLD, Australia.
Adenosine receptors (ARs) in the heart regulate vital functions like contraction and blood flow. Understanding AR interactions is key for developing targeted cardiovascular therapies.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- Adenosine levels increase with physiological stress, injury, and inflammation.
- Extracellular adenosine acts via G-protein coupled adenosine receptors (ARs) in cardiac cells.
- The four AR subtypes (A1, A2A, A2B, A3Rs) modulate diverse cardiovascular functions.
Purpose of the Study:
- To review the role of adenosine and ARs in cardiovascular control in health and disease.
- To explore the distinct and overlapping functions of AR subtypes in the heart.
- To discuss the therapeutic potential and challenges of AR-based pharmacotherapy.
Main Methods:
- Literature review of studies on adenosine and ARs in cardiovascular systems.
- Analysis of AR subtype functions and interactions.
- Discussion of therapeutic implications and challenges.
Main Results:
- ARs regulate myocardial contraction, heart rate, conduction, and vascular tone.
- ARs influence cardiac and vascular growth, inflammation, and cell survival.
- AR subtypes exhibit complex interactions in mediating cardiovascular responses.
Conclusions:
- Adenosine receptors are crucial for maintaining cardiovascular homeostasis and adaptation.
- Targeting ARs offers therapeutic potential for cardiovascular diseases.
- Challenges in AR-based therapy include receptor interactions and widespread distribution.
Related Concept Videos
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: ɑ and β-Receptor Blockers

